Attention-Deficit/Hyperactivity Disorder (ADHD): Advances in Diagnosis and Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 920
Special Issue Editor
Interests: attention-deficit/hyperactivity disorder; autistic spectrum disorders; substance use disorders; Parkinson’s disease; Alzheimer’s disease
Special Issue Information
Dear Colleagues,
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning. ADHD is one of the most common mental health disorders in children and adolescents and often persists into adulthood. Individuals with ADHD may face numerous challenges, including academic and occupational difficulties, strained interpersonal relationships, and increased risks for comorbid conditions such as anxiety, depression, and substance use disorders. Effective diagnosis and treatment are critical to managing ADHD symptoms and improving quality of life.
This Special Issue of the Journal of Clinical Medicine aims to highlight the latest research on ADHD, focusing on advancements in diagnosis, treatment, and long-term management. We invite original research articles and comprehensive reviews that investigate innovative diagnostic methods, address new pharmacological and non-pharmacological treatment options, and explore strategies for managing comorbid conditions. Our goal is to provide insights that improve clinical outcomes and support effective, individualized treatment approaches for people with ADHD across all ages.
We are particularly interested in manuscripts addressing the following areas:
- Advances in ADHD diagnostic tools: Including neuroimaging, genetic markers, and digital diagnostic applications;
- Pharmacological treatments: New medications, comparative studies of existing medications, and personalized medicine approaches for ADHD;
- Non-pharmacological interventions: Behavioral therapies, cognitive training, emerging digital therapeutics, and alternative medicine approaches;
- Long-term outcomes of ADHD treatment: Including impact on academic, occupational, and social functioning, as well as health outcomes;
- ADHD across the lifespan: Research focusing on diagnosis, management, and outcomes in childhood, adolescence, adulthood, and older adults;
- Comorbidities and dual diagnoses: Identification and management of co-occurring disorders, such as anxiety, depression, and substance use disorders, as well as somatic comorbidities;
- Patient and caregiver perspectives: Studies on quality of life, treatment adherence, and the psychosocial impact of ADHD;
- Innovative approaches in ADHD care: Use of artificial intelligence, machine learning, and digital tools to enhance diagnosis, treatment, and patient monitoring and provide coaching and support.
Through this Special Issue, we aim to gather a comprehensive selection of research that can inform and improve clinical practice, support effective management strategies, and ultimately enhance the lives of individuals affected by ADHD.
Dr. Yanli Zhang-James
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- attention-deficit/hyperactivity disorder
- neurodevelopmental disorder
- hyperactivity
- children
- adolescents
- adult
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.